Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
about
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightThe Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program.A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver DiseaseRe-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis.Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMSAstragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway.Uncoupling Protein 2 Inhibition Exacerbates Glucose Fluctuation-Mediated Neuronal Effects.High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus.The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
P2860
Q26752583-7E576A96-DD34-4C88-B80C-43F83192BDECQ37205472-C6CA4D90-A79C-413A-8113-1BDBC19FCAB7Q38872189-85003C5A-511D-46BD-8888-2EFC515D303BQ40364098-04B1B0E4-BBB4-46A9-8733-D03991FB4876Q41580240-8FB752AF-C89B-45A8-9B10-7D378056CDAAQ42991560-95B2EA43-6CAB-484F-94BE-FD9E2A62438CQ46311578-498ED535-1D1A-414C-AB51-BE6DA9C25F87Q47963224-6EF9ABA2-5993-4E52-AF48-D7C3B1E496B0Q53071821-A8D7DE58-EBF7-4A6B-BF02-B82CD59D9EC1Q55284601-3B7A6F19-3E6B-4421-8EF0-6623AC68286B
P2860
Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@ast
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@en
type
label
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@ast
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@en
prefLabel
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@ast
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@en
P2093
P2860
P1433
P1476
Glycemic variability is an ind ...... alcoholic fatty liver disease.
@en
P2093
Akira Hirose
Hideyuki Hyogo
Kazuaki Chayama
Kensuke Munekage
Kosei Masuda
Masafumi Ono
Motoi Hashiba
Narufumi Suganuma
Nobuto Okamoto
Reiko Yoshioka
P2860
P304
P356
10.1371/JOURNAL.PONE.0076161
P407
P577
2013-11-06T00:00:00Z